- April 26, 2021 BioSpace: Biotech SPACs Can Expect a Good Runway as Investors Focus on Quality
- April 2, 2021 BioSpace: Sepsis: Standard of Care Fails While Novel Meds and Diagnostics Go Unused
- March 17, 2021 BioWorld: Cervical cancer treatments bubbling in late-stage clinical efforts
- March 2, 2021 BioSpace: Determining Value is as Critical to Commercial Success as Clinical Data
- January 19, 2021 BioProcess International: AstraZeneca: ‘Manufacturing should take lion’s share of credit for vaccine success’
- January 15, 2021 BioSpace: Cell and Gene Therapies Shatter Prior Records, with Continued Growth Expected
- January 15, 2021 MM+M: Until we meet again: Reflections from a JPMorgan Health Conference like no other
- January 14, 2021 BioSpace: Drug Prices Top of Mind as Pharma Leaders Consider Policies Under Biden
- January 14, 2021 Fierce Biotech: JPM: Can we take J.P. Morgan out of San Francisco? We're virtually there
- January 8, 2021 BioSpace: China Showcase 2021 Highlights Trends and Areas Ripe for Investment
- January 8, 2021 STAT News: Even in a virtual JPM week, we need to maintain the relationship ‘glue’ that keeps the biotech industry strong
- January 6, 2021 The Science Advisory Board: COVID-19 to have long-lasting effect on biotech industry
- January 6, 2021 The Science Advisory Board: Top Operation Warp Speed official shares lessons learned from COVID-19
- December 18, 2020 BioSpace: Bioscience and Healthcare of the Future: Overrun by Choices, Changes and Opportunities
- November 23, 2020 BioSpace: SARS-CoV-2 Causes Heart Damage in 20% of People with Mild or No COVID-19 Symptoms
- November 9, 2020 BioSpace: Bioelectric Medicine Ready for Prime Time as Companies Advance Therapies
- November 5, 2020: BioSpace: SPACs Soar as Fast, Hassle-Free IPO Alternatives for Biotech Companies
- October 22, 2020 BioSpace: FDA Deputy Commissioner Discusses Modernization Strategies for Data and Trials
- October 7, 2020 PharmaIntelligence: Lessons From Biotech Entrepreneurs: Pitching Your First-In-Class Innovation
- October 5, 2020 InVivo: Femtech Presents Enticing Market Opportunity
- October 1, 2020 Contract Pharma: New York City is Not Dead, Our Life Sciences Sector is Thriving
- September 29, 2020 BioSpace: A Fireside Chat with J.P. Morgan’s Michael Gaito, Head of Healthcare Investment Banking
- September 17, 2020 BioSpace: Prepping for COVID-19’s Next Wave: Is the Glass Half Full or Half Empty?
- September 4, 2020 BioSpace: Lessons From Bergamo: Halting the Complement Cascade May Stop COVID-19 in Its Tracks
- September 3, 2020 BioSpace: Expert Panel Points to Central Role of Endothelial Injury and Lectin Pathway Activation in Critically Ill COVID-19 Patients
- July 22, 2020 PharmaIntelligence: Listening Well And Early To The Signs Of Alzheimer’s Disease
- July 13, 2020 PharmIntelligence: Alzheimer’s Is Not A Silent Disease If You Are Listening
- July 9, 2020 BioSpace: Alzheimer’s Drugs on Verge of Becoming Mainstream Medicine, but Early Intervention Still is Needed
- June 23, 2020 BioSpace: Drugging the Undruggable: How AI Does the (Almost) Impossible
- June 9, 2020 BioSpace: Personalization, Prediction and Prevention Drive the “Second Transformation of Medicine”
- January 13, 2020 Fierce Biotech: JPM: No sleep, exiled mattresses, cleared bank accounts: Getting deals done at JPM
- November 12, 2019 MedCity News: Digital Medicine & Medtech Showcase convenes in San Francisco January 13–15, 2020
What We Listen To
On the Big4Bio podcast, Demy-Colton's CEO Sara Demy talks about what's in store at Biotech Showcase, now in its 13th year - but virtual for the first time - and how to make the most of it.
Listen to the podcast here.
The top podcasts life science professionals should be listening to.
